Novel antiviral drug concept targets number of human viruses

In laboratory studies, an entirely new approach to antiviral drug development is showing remarkable effectiveness against herpes viruses, a large family of viruses associated with many human diseases. In addition, the innovative strategy targets these viruses at such a fundamental level that it may prove useful against a wide array of other viruses. And because the approach attacks viruses indirectly by making the cells they infect profoundly inhospitable to them, the likelihood that viral drug resistance will develop is thought to be extremely low.

University of Pennsylvania Medical Center researchers reported the findings in a study presented today at the Thirteenth International Conference on Antiviral Research in Baltimore, MD.

"This is a novel approach to the development of antiviral drugs," says Luis M. Schang, Ph.D., a postdoctoral fellow and first author on the study. "In the laboratory, we and others are seeing significant viral inhibition with drugs that have no toxicity to cells. If the strategy shows similar success in animals and, eventually, in humans, it should be applicable against many different kinds of viral infections."

Schang emphasizes that a good deal of work remains to be done before the new approach can be validated as a viable treatment for viral infections in humans.

Until now, antiviral drugs have sought to attack viruses directly by interfering with essential proteins produced by the viruses. Scientists have long known, however, that viruses are parasites and depend on the cells they infect for crucial support of their life cycles. Using the herpes simplex virus (HSV) as model target, the Penn team discovered that by inhibiting a particular set of cellular enzymes upon which the virus depends they can successfully block all viral activity while causing the host cells no ill effects.

"To date, all effective anti-viral drugs target viral proteins because the thought has been that knocking out a cellular

Contact: Franklin Hoke
University of Pennsylvania School of Medicine

Page: 1 2 3

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel flu vaccine shows promise in mice
11. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician

Post Your Comments:

(Date:11/19/2019)... , ... November 19, 2019 , ... Hosted at the ... , MJBizCon 2019 is the largest gathering of MJBiz business professionals in ... and programming to benefit every sector, there is no show quite like it. Atlantic ...
(Date:11/14/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... for stem cell treatment of knee osteoarthritis . The first treatment came shortly after ... Biopharma. , In July of 2019, PSC received FDA approval for a ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... leader in the design and manufacturer of technical ergonomic seating solutions, announced ... footrests compliant with Healthier Hospital Initiative guidelines. Established by Practice Greenhealth, a ...
Breaking Biology News(10 mins):
(Date:11/22/2019)... ... ... Lajollacooks4u is preparing for another busy holiday season. Not only has ... popular cooking classes and team-building events, but the company has also booked numerous companies ... a favorite for companies of all sizes since 2008. Each event is completely ...
(Date:11/12/2019)... , ... November 12, 2019 , ... ... solutions for the food and beverage industry launched a new innovative website. , ... digital experience. Now, the website offers global visitors updated ingredient usage tables by ...
(Date:11/6/2019)... ... 2019 , ... LeadingBiotech ,?an exclusive event series bringing ... East/West CEO conference to be held January 11-12, 2020 at the ... week of the J.P. Morgan Healthcare Conference and other biotech industry conferences, collectively ...
(Date:11/2/2019)... ... October 31, 2019 , ... Join ... in a live webinar on Friday, November 15, 2019 at 1pm ... Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has ...
Breaking Biology Technology:
Cached News: